Bald patch care: 5 sure-shot home remedies that help in hair regrowth in people suffering from Alopecia Areata

While medical treatments are usually the first port of call, a lot of people find a sense of peace (and some pretty great ...
WLKY on MSN

Project CommUNITY: A Women’s History Month story of identity, healing and alopecia

Providers say early treatment matters, especially for scarring hair loss, which can become permanent.

Mom Cuts 14 Inches of Her Hair to Make a Wig for Daughter, 3, with Alopecia — and Her Reaction Has Everyone in Tears (Exclusive)

"Seeing her smile was the best thing ever," Rubi Rojas tells PEOPLE of the moment her daughter Lorelai put on the wig made of her mom's hair ...
The American Journal of Managed Care

Noteworthy Studies on JAK Inhibitors, Skin-Gut Relationship in Alopecia Areata: Maria Hordinsky, MD

Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical ...
Dermatology Advisor

Switching Between JAK Inhibitors Can be Effective in Severe Alopecia Areata

Patients with alopecia areata who did not respond to initial treatment with a JAKi or who did not maintain response may ...
The American Journal of Managed Care

JAK Inhibitors Show Promise in Alopecia But Long-Term Management Requires More Study: Maria Hordinsky, MD

Janus kinase (JAK) inhibitors are a promising and new method of treating alopecia areata, giving doctors new options for ...

5 changes to your hair you shouldn't ignore and how they impact your health – from thinning to hair loss

Two trichologists explain the symptoms worth noticing, from harmless spots to warning signs ...
AOL

Alopecia: What to Know About Male Pattern Baldness

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...
Medscape

UK Approves New JAK Inhibitor for Severe Alopecia

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia

Xtressé™, the advanced hair health company founded by dermatologists and scientists, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) ...